Shanghai Aladdin Biochemical Technology Co., Ltd. engages in the research and development, and production of reagents. It operates through the following segments: High End Chemistry, Life Sciences, Analytical Chromatography, and Material Sciences. The High End Chemistry segment is composed of asymmetric synthesis; catalysis and inorganic chemistry; flavor and fragrance; organic building blocks; organometallic reagents; and synthetic reagents. The Life Sciences segment encompasses nutrition research, biochemical reagents, cancer research, cell biology and culture, molecular biology, metabolomics, and proteomics. The Analytical Chromatography segment consists of analysis reagents, gas chromatography, high pressure liquid chromatography, ion sensor materials, solvents, and resins. The Material Sciences segment covers alternative energy, biomaterials, metal and ceramic sciences, nanomaterials, and polymer sciences. The company was founded on March 16, 2009 and is headquartered in Shanghai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company